![]() |
|
|
Vol. 286, Issue 2, 772-779, August 1998
Laboratory of Pulmonary Pathobiology (J.M.S.P., D.C.Z.), Epoxyeicosatrienoic acids (EETs) and dihydroxyeicosatrienoic acids,
products of the cytochrome P450 arachidonic acid epoxygenase pathway,
have been shown to affect electrolyte transport in the kidney; however,
the effects of these compounds on airway epithelial ion transport have
not been investigated. Intact rat tracheas and primary cultures of rat
tracheal epithelial cells were mounted in Ussing chambers to monitor
changes in transepithelial voltage (Vt), short circuit current (Isc)
and electrical resistance (Rt), with or without the addition of
increasing concentrations (10
9-10
6 M) of
arachidonic acid, each of the four regioisomeric EETs and each of the
corresponding dihydroxyeicosatrienoic acids. In intact tracheas,
11,12-EET caused dose-dependent decreases in Vt and Isc (
Vt = 0.4 ± 0.1 mV,
Isc =
16.9 ± 5.4 µA/cm2 at 10
6 M, P < .05 vs. vehicle), whereas changes in Rt were not significantly different than vehicle alone. 11,12-dihydroxyeicosatrienoic acid caused
less impressive decreases in Vt and Isc, although arachidonic acid and
the other compounds tested were without significant effects. 11,12-EET
induced similar changes in cultured tracheal epithelial cell electrical
parameters at concentrations as low as 10
9 M. The effects
of 11,12-EET were highly stereoselective, with activity limited to
11(R),12(S)-EET, the least abundant rat lung enantiomer. Pretreatment
with amiloride or mucosal exposure to sodium free media did not
significantly alter the 11,12-EET-induced changes in Vt. In contrast,
pretreatment with bumetanide abolished the 11,12-EET electrophysiologic
effects, suggesting that these effects may be mediated through
inhibition of a chloride conductive pathway. We conclude that
arachidonic acid epoxygenase metabolites cause significant changes in
rat airway electrical parameters and may be involved in the control of
lung fluid and electrolyte transport.
0022-3565/98/2862-0772$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
B. D. Przybyla-Zawislak, P. K. Srivastava, J. Vazquez-Matias, H. W. Mohrenweiser, J. E. Maxwell, B. D. Hammock, J. A. Bradbury, A. E. Enayetallah, D. C. Zeldin, and D. F. Grant Polymorphisms in Human Soluble Epoxide Hydrolase Mol. Pharmacol., August 1, 2003; 64(2): 482 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Tsao, S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot, J. A. Goldstein, and D. C. Zeldin Identification and Localization of Five CYP2Cs in Murine Extrahepatic Tissues and Their Metabolism of Arachidonic Acid to Regio- and Stereoselective Products J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 39 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Jacobs and D. C. Zeldin The lung HETEs (and EETs) up Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ma, W. Qu, P. E. Scarborough, K. B. Tomer, C. R. Moomaw, R. Maronpot, L. S. Davis, M. D. Breyer, and D. C. Zeldin Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney J. Biol. Chem., June 18, 1999; 274(25): 17777 - 17788. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Zeldin Epoxygenase Pathways of Arachidonic Acid Metabolism J. Biol. Chem., September 21, 2001; 276(39): 36059 - 36062. [Full Text] [PDF] |
||||